The short version
What teams need to understand
- Pharmacovigilance systems must monitor training compliance using defined metrics.
- Training completion must be tracked at individual, role, and organisational level.
- Metrics must include completion rates, overdue training, and compliance percentages.
- Training compliance must be reviewed regularly and reported to management.
- Non-compliance must be identified, followed up, and escalated where necessary.
- Inspection-ready evidence must demonstrate active monitoring and control of training compliance.
Regulatory expectation
What regulators expect
Each expectation should be supported by controlled documentation, traceable records, clear ownership, and evidence that the process works in practice.
- Training compliance must be actively monitored.
- Training completion must be measurable.
- Overdue training must be identified and managed.
- Training metrics must be reviewed regularly.
- Non-compliance must be escalated and addressed.
Why it matters
What this means in practice
Inspectors assess whether pharmacovigilance systems actively monitor training compliance. They review training metrics, completion rates, overdue training, and evidence that non-compliance is identified, managed, and escalated appropriately.
Questions this page answers
Inspection evidence
Evidence teams should be able to show
Training Compliance Tracker
- Team or department-level compliance reports
- Percentage completion of required training
- Overdue training counts
- Regular updates showing training status
Training Metrics and Reporting
- Monthly or quarterly training compliance reports
- Compliance percentage calculations
- Trend analysis of training completion over time
- Management-level reporting of training status
Overdue Training Monitoring
- Identification of overdue training by individual
- Tracking of delayed completion
- Follow-up actions for non-compliance
- Escalation of persistent overdue training
Training Compliance Governance
- Review of training metrics by PV training lead or QA
- Management review of compliance reports
- Defined escalation pathways for non-compliance
- Documentation of actions taken to address gaps
Corrective Actions for Non-Compliance
- Follow-up by line managers
- Retraining requirements for missed training
- Escalation to QA or senior management
- Documentation of compliance recovery actions
Regulatory Basis (Primary Sources)
- GVP Module I - requirement for trained personnel and oversight of competence
- GVP Module II - requirement for documentation supporting PV system operation
- ICH E2D - expectation for trained personnel managing safety data
- MHRA GPvP guidance - expectations for monitoring training compliance
- FDA pharmacovigilance guidance - requirement for ensuring trained and competent staff
Typical Inspection Questions (What Inspectors Ask)
- How do you monitor training compliance?
- Show me your training compliance metrics.
- How do you identify overdue training?
- What happens when training is not completed on time?
- How is training compliance reported to management?
Common failure patterns
What good looks like
- Clear tracking of training completion and compliance.
- Regular reporting of training metrics.
- Identification and management of overdue training.
- Active governance and review of training compliance.
- Effective escalation and resolution of non-compliance.
How teams operationalise it
- Implement a training compliance tracker or system.
- Define metrics such as completion rates and overdue training.
- Review training compliance regularly.
- Follow up with individuals who have overdue training.
- Escalate persistent non-compliance.
- Report training compliance to management.
From expectation to working control
Find the documentation that supports this work
Review the related toolkit to understand its purpose, included files, and how it supports this regulatory expectation.
Frequently asked questions
How is training compliance monitored in pharmacovigilance?
Training compliance is monitored using trackers or systems that record completion rates, overdue training, and compliance metrics across individuals and teams.
What metrics are used to measure training compliance?
Common metrics include percentage of completed training, number of overdue courses, compliance rate by department, and trends over time.
What happens if training is overdue in pharmacovigilance?
Overdue training must be followed up by line managers and escalated if not completed, with corrective actions taken to restore compliance.
Do inspectors review training compliance metrics?
Yes. Inspectors review training metrics and compliance reports to confirm that training is actively monitored and controlled.
How often should training compliance be reviewed?
Training compliance is typically reviewed monthly or quarterly, depending on organisational requirements and risk.
Why is training compliance monitoring important?
Monitoring ensures that all personnel remain trained and compliant, reducing regulatory risk and maintaining system integrity.
Source boundary
Regulatory sources
These primary sources inform this structured interpretation. Always confirm current requirements against the original source and the requirements applicable to your organisation, product, and jurisdiction.
European Medicines Agency (EMA)
Guideline on good pharmacovigilance practices (GVP) - Module I
View sourceGuideline on good pharmacovigilance practices (GVP) - Module II
View source
FDA
21 CFR Part 11 - Electronic Records
View source
ICH
Post-Approval Safety Data Management (E2D)
View source
MHRA
Good Pharmacovigilance Practice (GPvP)
View source